Strongbridge Biopharma is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing and commercializing of some of their medical products and therapies.
The company stated in the following article that they conduct pre-clinical trials of their drugs on animals.
“Strongbridge has also confirmed the completion of the manufacture of a batch of non GMP ATL1103 compound and has used some of this material in certain animal safety studies that it had initiated to support long term clinical development of ATL1103 .” Read the following article
Strongbridge Biopharma plc, incorporated on May 26, 2015, is a global commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for a range of diseases. The Company’s commercial product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokalemic and related variants of primary periodic paralysis, a neuromuscular disorder. [Source: Reuters]
Company Website: http://www.strongbridgebio.com